Desfern (desferrioxamine mesylate for injection)

Desferoxamine mesylate for injection
[Trade name] Desferoxamine
[Common name] Desferrioxamine mesylate for injection
[English name]
[Main ingredient] Desferrioxamine mesylate
[Character] This product is white to off-white loose lumps or powder
[Indications] Treatment of chronic iron overload, such as iron deficiency caused by blood transfusion Hemosiderinosis, such as thalassemia major, sideroblastic anemia, autoimmune hemolytic anemia, and other chronic anemias. Patients with idiopathic primary hemochromatosis suffer from concomitant diseases such as severe anemia, heart disease, and hypoalbuminemia. Impedes phlebotomy Iron overload due to cutaneous porphyria tarda, inability to perform phlebotomy Treatment of acute iron poisoning Treatment of advanced renal failure Chronic aluminum overload in maintenance dialysis patients with the following conditions Aluminum related Bone disease, and/or dialytic encephalopathy, and/or aluminum-related anemia
[Usage and Dosage] On days of chronic iron overload, subcutaneous intravenous and intramuscular injection of iron poisoning should not exceed the day of aluminum overload in patients with end-stage renal failure/, every Peripheral intramuscular injection overload test, aluminum overload test/, slow intravenous injection
[Adverse reactions] Common injection site symptoms, often accompanied by joint pain, myalgia, headache, urticaria diagnosis and fever, developmental delay and hip changes, uncommon and rare vision Yili disorder, rare acute respiratory distress syndrome, dizziness, dialysis encephalopathy, peripheral sensorimotor or mixed neuropathy, renal function impairment, hemogram abnormality, widespread rash, allergic/anaphylactic-like reaction, susceptibility to Yersinia and mucormycosis.
【Contraindications】Patients known to be allergic to active substances, excluding patients who undergo subsequent treatment.
[Use by pregnant and lactating women] Use with caution by pregnant and lactating women.
[Precautions] Rapid intravenous infusion of this drug solution at a concentration greater than 100 can cause renal damage, vision and hearing impairment, developmental delay, especially acute respiratory distress syndrome in children under 10 years of age when treatment is first started, especially serum iron concentration. On the low side, after using this medicine in large doses. Eye and hearing tests should be performed before and during treatment, and children's weight and height should be monitored. Iron overload increases susceptibility to Yersinia enterocolitis and Yersinia pseudotuberculosis-type infections. If such an infection occurs while using this medicine, the medicine should be stopped immediately until the infection is successfully cured. Rare cases of mucormycosis have been reported, in which case the drug should be discontinued and antifungal treatment should be given immediately. Large doses of this drug worsen neurological deficits in patients with aluminum-associated encephalopathy.
[Dosage form] Injection
[Specification]/box
[Price] Yuan/box
[Storage] Store below ℃
[Validity period] Months
[Registration number]
[Manufacturer] Swiss Novartis Pharmaceuticals Co., Ltd.
[Warm reminder] Product content and pictures are for customer reference only. Please follow the doctor's guidance for actual diagnosis and medication! Please note that our company strictly abides by While ensuring quality, the price of medicines has been reduced to the lowest level, so that patients can get real benefits. It truly benefits the people and is affordable to the end! For ordering, please contact Mr. Gu Minyou